Insider transactions

EDGAR

Iambic Therapeutics, Inc.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-21.

Open-market purchases (code P)
1 transactions, 718,750 shares
Sum of shares × price per share: 11,500,000
Open-market sales (code S)
0 transactions, — shares

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–49 of 49

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-10-16 Filed 2026-10-19RASTETTER WILLIAM H Director · Other: Chairperson of the Board
C

Conversion of derivative security

Common Stock
Acquired (A)192,579——192,579Indirect (I) See footnoteNo
F1, F2, F3, F4, F5
  • F1 Each share of Series B Convertible Preferred Stock automatically converted into Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date.
  • F2 Each share of Series B-2 Convertible Preferred Stock automatically converted into Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date.
  • F3 Each share of Series B-3 Convertible Preferred Stock automatically converted into Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date.
  • F4 Each share of Series B-4 Convertible Preferred Stock automatically converted into Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date.
  • F5 The shares are held of record by the Rastetter Family Trust dated September 2, 2010, for which Dr. Rastetter serves as a trustee.
Open filing 0001205903-26-000013 Read from the filing’s XML Dispute this row
2026-10-16 Filed 2026-10-19RASTETTER WILLIAM H Director · Other: Chairperson of the Board
C

Conversion of derivative security

Common Stock
Acquired (A)8,341——200,920Indirect (I) See footnoteNo
F6, F5
  • F6 The conversion price was equal to 85% of the Issuer's initial public offering price of $16.00 per share (reflecting a 15% discount).
  • F5 The shares are held of record by the Rastetter Family Trust dated September 2, 2010, for which Dr. Rastetter serves as a trustee.
Open filing 0001205903-26-000013 Read from the filing’s XML Dispute this row
2026-10-16 Filed 2026-10-19RASTETTER WILLIAM H Director · Other: Chairperson of the Board
C

Conversion of derivative security

Derivative security: Series B Convertible Preferred Stock — underlying Common Stock (76,801)
Disposed (D)76,8010—0Indirect (I) See footnoteNo
F1, F5
  • F1 Each share of Series B Convertible Preferred Stock automatically converted into Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date.
  • F5 The shares are held of record by the Rastetter Family Trust dated September 2, 2010, for which Dr. Rastetter serves as a trustee.
Open filing 0001205903-26-000013 Read from the filing’s XML Dispute this row
2026-10-16 Filed 2026-10-19RASTETTER WILLIAM H Director · Other: Chairperson of the Board
C

Conversion of derivative security

Derivative security: Series B-2 Convertible Preferred Stock — underlying Common Stock (64,001)
Disposed (D)64,0010—0Indirect (I) See footnoteNo
F2, F5
  • F2 Each share of Series B-2 Convertible Preferred Stock automatically converted into Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date.
  • F5 The shares are held of record by the Rastetter Family Trust dated September 2, 2010, for which Dr. Rastetter serves as a trustee.
Open filing 0001205903-26-000013 Read from the filing’s XML Dispute this row
2026-10-16 Filed 2026-10-19RASTETTER WILLIAM H Director · Other: Chairperson of the Board
C

Conversion of derivative security

Derivative security: Series B-3 Convertible Preferred Stock — underlying Common Stock (36,805)
Disposed (D)36,8050—0Indirect (I) See footnoteNo
F3, F5
  • F3 Each share of Series B-3 Convertible Preferred Stock automatically converted into Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date.
  • F5 The shares are held of record by the Rastetter Family Trust dated September 2, 2010, for which Dr. Rastetter serves as a trustee.
Open filing 0001205903-26-000013 Read from the filing’s XML Dispute this row
2026-10-16 Filed 2026-10-19RASTETTER WILLIAM H Director · Other: Chairperson of the Board
C

Conversion of derivative security

Derivative security: Series B-4 Convertible Preferred Stock — underlying Common Stock (14,972)
Disposed (D)14,9720—0Indirect (I) See footnoteNo
F4, F5
  • F4 Each share of Series B-4 Convertible Preferred Stock automatically converted into Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date.
  • F5 The shares are held of record by the Rastetter Family Trust dated September 2, 2010, for which Dr. Rastetter serves as a trustee.
Open filing 0001205903-26-000013 Read from the filing’s XML Dispute this row
2026-10-16 Filed 2026-10-19RASTETTER WILLIAM H Director · Other: Chairperson of the Board
C

Conversion of derivative security

Derivative security: Convertible Promissory Notes — underlying Common Stock (8,341)
Disposed (D)8,3410—0Indirect (I) See footnoteNo
F6, F5
  • F6 The conversion price was equal to 85% of the Issuer's initial public offering price of $16.00 per share (reflecting a 15% discount).
  • F5 The shares are held of record by the Rastetter Family Trust dated September 2, 2010, for which Dr. Rastetter serves as a trustee.
Open filing 0001205903-26-000013 Read from the filing’s XML Dispute this row
2026-10-16 Filed 2026-10-19Vogelstein R Jacob Director
C

Conversion of derivative security

Common Stock
Acquired (A)1,995,749——1,995,749Indirect (I) See footnoteNo
F1, F2, F3, F4
  • F1 Each share of Series A Convertible Preferred Stock automatically converted into Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date.
  • F2 Each share of Series B Convertible Preferred Stock automatically converted into Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date.
  • F3 Each share of Series B-3 Convertible Preferred Stock automatically converted into Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date.
  • F4 The shares are held of record by Catalio Nexus Fund III, LP, or Catalio Nexus. Catalio Capital Management, LP, or Catalio Capital Mgmt, a registered investment advisor, is the investment manager for Catalio Nexus. As a managing partner of Catalio Capital Mgmt, the reporting person shares voting and dispositive power with respect to the shares held by Catalio Nexus. The reporting person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Exchange Act, except to the extent of his pecuniary interest therein, if any.
Open filing 0002154030-26-000007 Read from the filing’s XML Dispute this row
2026-10-16 Filed 2026-10-19Vogelstein R Jacob Director
C

Conversion of derivative security

Common Stock
Acquired (A)1,458,290——1,458,290Indirect (I) See footnoteNo
F5, F6
  • F5 Each share of Series B-4 Convertible Preferred Stock automatically converted into Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date.
  • F6 The shares are held of record by Catalio Access Fund VIII, LLC, or Catalio Access. Catalio Capital Mgmt provides investment management services for Catalio Access. As a managing partner of Catalio Capital Mgmt, the reporting person shares voting and dispositive power with respect to the shares held by Catalio Access.The reporting person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Exchange Act, except to the extent of his pecuniary interest therein, if any.
Open filing 0002154030-26-000007 Read from the filing’s XML Dispute this row
2026-10-16 Filed 2026-10-19Vogelstein R Jacob Director
C

Conversion of derivative security

Common Stock
Acquired (A)742,546——742,546Indirect (I) See footnoteNo
F7, F8
  • F7 The conversion price was equal to 85% of the Issuer's initial public offering price of $16.00 per share (reflecting a 15% discount).
  • F8 The shares are held of record by Catalio BH SPV, LLC, or Catalio SPV. Catalio Capital Mgmt is the investment manager for Catalio SPV. As a managing partner of Catalio Capital Mgmt, the reporting person shares voting and dispositive power with respect to the shares held by Catalio SPV. The reporting person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Exchange Act, except to the extent of his pecuniary interest therein, if any.
Open filing 0002154030-26-000007 Read from the filing’s XML Dispute this row
2026-10-16 Filed 2026-10-19Vogelstein R Jacob Director
C

Conversion of derivative security

Derivative security: Series A Convertible Preferred Stock — underlying Common Stock (1,141,878)
Disposed (D)1,141,8780—0Indirect (I) See footnoteNo
F1, F4
  • F1 Each share of Series A Convertible Preferred Stock automatically converted into Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date.
  • F4 The shares are held of record by Catalio Nexus Fund III, LP, or Catalio Nexus. Catalio Capital Management, LP, or Catalio Capital Mgmt, a registered investment advisor, is the investment manager for Catalio Nexus. As a managing partner of Catalio Capital Mgmt, the reporting person shares voting and dispositive power with respect to the shares held by Catalio Nexus. The reporting person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Exchange Act, except to the extent of his pecuniary interest therein, if any.
Open filing 0002154030-26-000007 Read from the filing’s XML Dispute this row
2026-10-16 Filed 2026-10-19Vogelstein R Jacob Director
C

Conversion of derivative security

Derivative security: Series B Convertible Preferred Stock — underlying Common Stock (731,187)
Disposed (D)731,1870—0Indirect (I) See footnoteNo
F2, F4
  • F2 Each share of Series B Convertible Preferred Stock automatically converted into Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date.
  • F4 The shares are held of record by Catalio Nexus Fund III, LP, or Catalio Nexus. Catalio Capital Management, LP, or Catalio Capital Mgmt, a registered investment advisor, is the investment manager for Catalio Nexus. As a managing partner of Catalio Capital Mgmt, the reporting person shares voting and dispositive power with respect to the shares held by Catalio Nexus. The reporting person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Exchange Act, except to the extent of his pecuniary interest therein, if any.
Open filing 0002154030-26-000007 Read from the filing’s XML Dispute this row
2026-10-16 Filed 2026-10-19Vogelstein R Jacob Director
C

Conversion of derivative security

Derivative security: Series B-3 Convertible Preferred Stock — underlying Common Stock (122,684)
Disposed (D)122,6840—0Indirect (I) See footnoteNo
F3, F4
  • F3 Each share of Series B-3 Convertible Preferred Stock automatically converted into Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date.
  • F4 The shares are held of record by Catalio Nexus Fund III, LP, or Catalio Nexus. Catalio Capital Management, LP, or Catalio Capital Mgmt, a registered investment advisor, is the investment manager for Catalio Nexus. As a managing partner of Catalio Capital Mgmt, the reporting person shares voting and dispositive power with respect to the shares held by Catalio Nexus. The reporting person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Exchange Act, except to the extent of his pecuniary interest therein, if any.
Open filing 0002154030-26-000007 Read from the filing’s XML Dispute this row
2026-10-16 Filed 2026-10-19Vogelstein R Jacob Director
C

Conversion of derivative security

Derivative security: Series B-4 Convertible Preferred Stock — underlying Common Stock (1,458,290)
Disposed (D)1,458,2900—0Indirect (I) See footnoteNo
F5, F6
  • F5 Each share of Series B-4 Convertible Preferred Stock automatically converted into Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date.
  • F6 The shares are held of record by Catalio Access Fund VIII, LLC, or Catalio Access. Catalio Capital Mgmt provides investment management services for Catalio Access. As a managing partner of Catalio Capital Mgmt, the reporting person shares voting and dispositive power with respect to the shares held by Catalio Access.The reporting person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Exchange Act, except to the extent of his pecuniary interest therein, if any.
Open filing 0002154030-26-000007 Read from the filing’s XML Dispute this row
2026-10-16 Filed 2026-10-19Vogelstein R Jacob Director
C

Conversion of derivative security

Derivative security: Convertible Promissory Notes — underlying Common Stock (742,546)
Disposed (D)742,5460—0Indirect (I) See footnoteNo
F7, F8
  • F7 The conversion price was equal to 85% of the Issuer's initial public offering price of $16.00 per share (reflecting a 15% discount).
  • F8 The shares are held of record by Catalio BH SPV, LLC, or Catalio SPV. Catalio Capital Mgmt is the investment manager for Catalio SPV. As a managing partner of Catalio Capital Mgmt, the reporting person shares voting and dispositive power with respect to the shares held by Catalio SPV. The reporting person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Exchange Act, except to the extent of his pecuniary interest therein, if any.
Open filing 0002154030-26-000007 Read from the filing’s XML Dispute this row
2026-10-16 Filed 2026-10-19Secora Michael Officer: CFO Chief Corp Dev Ofcr
C

Conversion of derivative security

Common Stock
Acquired (A)61,342——279,902Direct (D) No
F1
  • F1 Each share of Series B-3 Convertible Preferred Stock automatically converted into Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date.
Open filing 0001855980-26-000009 Read from the filing’s XML Dispute this row
2026-10-16 Filed 2026-10-19Secora Michael Officer: CFO Chief Corp Dev Ofcr
C

Conversion of derivative security

Derivative security: Series B-3 Convertible Preferred Stock — underlying Common Stock (61,342)
Disposed (D)61,3420—0Direct (D) No
F1
  • F1 Each share of Series B-3 Convertible Preferred Stock automatically converted into Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date.
Open filing 0001855980-26-000009 Read from the filing’s XML Dispute this row
2026-10-16 Filed 2026-10-19Catalio Capital Management, LP 10% ownerCatalio Nexus Fund III, LP 10% ownerCatalio Access Fund VIII, LLC 10% ownerCatalio BH SPV, LLC 10% ownerPetrocheilos George C 10% owner
C

Conversion of derivative security

Common Stock
Acquired (A)1,995,749——1,995,749Indirect (I) See footnoteNo
F1, F2, F3, F4
  • F1 Each share of Series A Convertible Preferred Stock automatically converted into Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date.
  • F2 Each share of Series B Convertible Preferred Stock automatically converted into Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date.
  • F3 Each share of Series B-3 Convertible Preferred Stock automatically converted into Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date.
  • F4 The shares are held of record by Catalio Nexus Fund III, LP, or Catalio Nexus. Catalio Capital Management, LP, or Catalio Capital Mgmt, a registered investment adviser, is the investment manager for Catalio Nexus. R. Jacob Vogelstein and George C. Petrocheilos are managing partners of Catalio Capital Mgmt. Messrs. Vogelstein and Petrocheilos share voting and dispositive power with respect to the shares held by Catalio Nexus. Catalio Capital Mgmt, Mr. Vogelstein and Mr. Petrocheilos each disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein, if any.
Open filing 0001958125-26-000011 Read from the filing’s XML Dispute this row
2026-10-16 Filed 2026-10-19Catalio Capital Management, LP 10% ownerCatalio Nexus Fund III, LP 10% ownerCatalio Access Fund VIII, LLC 10% ownerCatalio BH SPV, LLC 10% ownerPetrocheilos George C 10% owner
C

Conversion of derivative security

Common Stock
Acquired (A)1,458,290——1,458,290Indirect (I) See footnoteNo
F5, F6
  • F5 Each share of Series B-4 Convertible Preferred Stock automatically converted into Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date.
  • F6 The shares are held of record by Catalio Access Fund VIII, LLC, or Catalio Access. Catalio Capital Mgmt provides investment management services for Catalio Access. R. Jacob Vogelstein and George C. Petrocheilos are managing partners of Catalio Capital Mgmt. Messrs. Vogelstein and Petrocheilos share voting and dispositive power with respect to the shares held by Catalio Access. Catalio Capital Mgmt, Mr. Voglestein and Mr. Petrocheilos each disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein, if any.
Open filing 0001958125-26-000011 Read from the filing’s XML Dispute this row
2026-10-16 Filed 2026-10-19Catalio Capital Management, LP 10% ownerCatalio Nexus Fund III, LP 10% ownerCatalio Access Fund VIII, LLC 10% ownerCatalio BH SPV, LLC 10% ownerPetrocheilos George C 10% owner
C

Conversion of derivative security

Common Stock
Acquired (A)742,546——742,546Indirect (I) See footnoteNo
F7, F8
  • F7 The conversion price was equal to 85% of the Issuer's initial public offering price of $16.00 per share (reflecting a 15% discount).
  • F8 The shares are held of record by Catalio BH SPV, LLC, or Catalio SPV. Catalio Capital Mgmt is the investment manager for Catalio SPV. R. Jacob Vogelstein and George C. Petrocheilos are managing partners of Catalio Capital Mgmt. Messrs. Vogelstein and Petrocheilos share voting and dispositive power with respect to the shares held by Catalio SPV. Catalio Capital Mgmt, Mr. Vogelstein and Mr. Petrocheilos each disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein, if any.
Open filing 0001958125-26-000011 Read from the filing’s XML Dispute this row
2026-10-16 Filed 2026-10-19Catalio Capital Management, LP 10% ownerCatalio Nexus Fund III, LP 10% ownerCatalio Access Fund VIII, LLC 10% ownerCatalio BH SPV, LLC 10% ownerPetrocheilos George C 10% owner
C

Conversion of derivative security

Derivative security: Series A Convertible Preferred Stock — underlying Common Stock (1,141,878)
Disposed (D)1,141,8780—0Indirect (I) See foonoteNo
F1, F4
  • F1 Each share of Series A Convertible Preferred Stock automatically converted into Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date.
  • F4 The shares are held of record by Catalio Nexus Fund III, LP, or Catalio Nexus. Catalio Capital Management, LP, or Catalio Capital Mgmt, a registered investment adviser, is the investment manager for Catalio Nexus. R. Jacob Vogelstein and George C. Petrocheilos are managing partners of Catalio Capital Mgmt. Messrs. Vogelstein and Petrocheilos share voting and dispositive power with respect to the shares held by Catalio Nexus. Catalio Capital Mgmt, Mr. Vogelstein and Mr. Petrocheilos each disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein, if any.
Open filing 0001958125-26-000011 Read from the filing’s XML Dispute this row
2026-10-16 Filed 2026-10-19Catalio Capital Management, LP 10% ownerCatalio Nexus Fund III, LP 10% ownerCatalio Access Fund VIII, LLC 10% ownerCatalio BH SPV, LLC 10% ownerPetrocheilos George C 10% owner
C

Conversion of derivative security

Derivative security: Series B Convertible Preferred Stock — underlying Common Stock (731,187)
Disposed (D)731,1870—0Indirect (I) See footnoteNo
F2, F4
  • F2 Each share of Series B Convertible Preferred Stock automatically converted into Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date.
  • F4 The shares are held of record by Catalio Nexus Fund III, LP, or Catalio Nexus. Catalio Capital Management, LP, or Catalio Capital Mgmt, a registered investment adviser, is the investment manager for Catalio Nexus. R. Jacob Vogelstein and George C. Petrocheilos are managing partners of Catalio Capital Mgmt. Messrs. Vogelstein and Petrocheilos share voting and dispositive power with respect to the shares held by Catalio Nexus. Catalio Capital Mgmt, Mr. Vogelstein and Mr. Petrocheilos each disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein, if any.
Open filing 0001958125-26-000011 Read from the filing’s XML Dispute this row
2026-10-16 Filed 2026-10-19Catalio Capital Management, LP 10% ownerCatalio Nexus Fund III, LP 10% ownerCatalio Access Fund VIII, LLC 10% ownerCatalio BH SPV, LLC 10% ownerPetrocheilos George C 10% owner
C

Conversion of derivative security

Derivative security: Series B-3 Convertible Preferred Stock — underlying Common Stock (122,684)
Disposed (D)122,6840—0Indirect (I) See footnoteNo
F3, F4
  • F3 Each share of Series B-3 Convertible Preferred Stock automatically converted into Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date.
  • F4 The shares are held of record by Catalio Nexus Fund III, LP, or Catalio Nexus. Catalio Capital Management, LP, or Catalio Capital Mgmt, a registered investment adviser, is the investment manager for Catalio Nexus. R. Jacob Vogelstein and George C. Petrocheilos are managing partners of Catalio Capital Mgmt. Messrs. Vogelstein and Petrocheilos share voting and dispositive power with respect to the shares held by Catalio Nexus. Catalio Capital Mgmt, Mr. Vogelstein and Mr. Petrocheilos each disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein, if any.
Open filing 0001958125-26-000011 Read from the filing’s XML Dispute this row
2026-10-16 Filed 2026-10-19Catalio Capital Management, LP 10% ownerCatalio Nexus Fund III, LP 10% ownerCatalio Access Fund VIII, LLC 10% ownerCatalio BH SPV, LLC 10% ownerPetrocheilos George C 10% owner
C

Conversion of derivative security

Derivative security: Series B-4 Convertible Preferred Stock — underlying Common Stock (1,458,290)
Disposed (D)1,458,2900—0Indirect (I) See footnoteNo
F5, F6
  • F5 Each share of Series B-4 Convertible Preferred Stock automatically converted into Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date.
  • F6 The shares are held of record by Catalio Access Fund VIII, LLC, or Catalio Access. Catalio Capital Mgmt provides investment management services for Catalio Access. R. Jacob Vogelstein and George C. Petrocheilos are managing partners of Catalio Capital Mgmt. Messrs. Vogelstein and Petrocheilos share voting and dispositive power with respect to the shares held by Catalio Access. Catalio Capital Mgmt, Mr. Voglestein and Mr. Petrocheilos each disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein, if any.
Open filing 0001958125-26-000011 Read from the filing’s XML Dispute this row
2026-10-16 Filed 2026-10-19Catalio Capital Management, LP 10% ownerCatalio Nexus Fund III, LP 10% ownerCatalio Access Fund VIII, LLC 10% ownerCatalio BH SPV, LLC 10% ownerPetrocheilos George C 10% owner
C

Conversion of derivative security

Derivative security: Convertible Promissory Notes — underlying Common Stock (742,546)
Disposed (D)742,5460—0Indirect (I) See footnoteNo
F7, F8
  • F7 The conversion price was equal to 85% of the Issuer's initial public offering price of $16.00 per share (reflecting a 15% discount).
  • F8 The shares are held of record by Catalio BH SPV, LLC, or Catalio SPV. Catalio Capital Mgmt is the investment manager for Catalio SPV. R. Jacob Vogelstein and George C. Petrocheilos are managing partners of Catalio Capital Mgmt. Messrs. Vogelstein and Petrocheilos share voting and dispositive power with respect to the shares held by Catalio SPV. Catalio Capital Mgmt, Mr. Vogelstein and Mr. Petrocheilos each disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein, if any.
Open filing 0001958125-26-000011 Read from the filing’s XML Dispute this row
2026-10-16 Filed 2026-10-19Rachlin Evan Lockwood Director
C

Conversion of derivative security

Common Stock
Acquired (A)1,458,736——1,458,736Indirect (I) See footnoteNo
F1, F2, F3
  • F1 Each share of Series B Convertible Preferred Stock automatically converted into Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date.
  • F2 Each share of Series B-3 Convertible Preferred Stock automatically converted into Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date.
  • F3 The shares are held of record by Ascenta Capital Fund I, L.P., or Ascenta Capital Fund I. As a Managing Member of Ascenta Capital Fund I, G.P., L.L.C., the General Partner of Ascenta Capital Fund I, the reporting person shares voting and dispositive power with respect to the shares held of record by Ascenta Capital Fund I. The reporting person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Exchange Act, except to the extent of his pecuniary interest therein, if any.
Open filing 0002151678-26-000007 Read from the filing’s XML Dispute this row
2026-10-16 Filed 2026-10-19Rachlin Evan Lockwood Director
C

Conversion of derivative security

Common Stock
Acquired (A)410,762——1,869,498Indirect (I) See footnoteNo
F4, F3
  • F4 The conversion price was equal to 85% of the Issuer's initial public offering price of $16.00 per share (reflecting a 15% discount).
  • F3 The shares are held of record by Ascenta Capital Fund I, L.P., or Ascenta Capital Fund I. As a Managing Member of Ascenta Capital Fund I, G.P., L.L.C., the General Partner of Ascenta Capital Fund I, the reporting person shares voting and dispositive power with respect to the shares held of record by Ascenta Capital Fund I. The reporting person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Exchange Act, except to the extent of his pecuniary interest therein, if any.
Open filing 0002151678-26-000007 Read from the filing’s XML Dispute this row
2026-10-16 Filed 2026-10-19Rachlin Evan Lockwood Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)718,75016
11,500,000

Derived: shares × price per share. Exact value 11500000.

2,588,248Indirect (I) See footnoteNo
F3
  • F3 The shares are held of record by Ascenta Capital Fund I, L.P., or Ascenta Capital Fund I. As a Managing Member of Ascenta Capital Fund I, G.P., L.L.C., the General Partner of Ascenta Capital Fund I, the reporting person shares voting and dispositive power with respect to the shares held of record by Ascenta Capital Fund I. The reporting person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Exchange Act, except to the extent of his pecuniary interest therein, if any.
Open filing 0002151678-26-000007 Read from the filing’s XML Dispute this row
2026-10-16 Filed 2026-10-19Rachlin Evan Lockwood Director
C

Conversion of derivative security

Common Stock
Acquired (A)57,754——57,754Indirect (I) See footnoteNo
F1, F5
  • F1 Each share of Series B Convertible Preferred Stock automatically converted into Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date.
  • F5 The shares are held of record by Ascenta Capital Project Turing SPV, L.P., or Ascenta Capital Project Turing. As a Managing Member of Ascenta Capital Fund I, G.P., L.L.C., the General Partner of Ascenta Capital Project Turing, the reporting person shares voting and dispositive power with respect to the shares held of record by Ascenta Capital Project Turing. The reporting person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Exchange Act, except to the extent of his pecuniary interest therein, if any.
Open filing 0002151678-26-000007 Read from the filing’s XML Dispute this row
2026-10-16 Filed 2026-10-19Rachlin Evan Lockwood Director
C

Conversion of derivative security

Derivative security: Series B Convertible Preferred Stock — underlying Common Stock (1,152,025)
Disposed (D)1,152,0250—0Indirect (I) See footnoteNo
F1, F3
  • F1 Each share of Series B Convertible Preferred Stock automatically converted into Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date.
  • F3 The shares are held of record by Ascenta Capital Fund I, L.P., or Ascenta Capital Fund I. As a Managing Member of Ascenta Capital Fund I, G.P., L.L.C., the General Partner of Ascenta Capital Fund I, the reporting person shares voting and dispositive power with respect to the shares held of record by Ascenta Capital Fund I. The reporting person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Exchange Act, except to the extent of his pecuniary interest therein, if any.
Open filing 0002151678-26-000007 Read from the filing’s XML Dispute this row
2026-10-16 Filed 2026-10-19Rachlin Evan Lockwood Director
C

Conversion of derivative security

Derivative security: Series B Convertible Preferred Stock — underlying Common Stock (57,754)
Disposed (D)57,7540—0Indirect (I) See footnoteNo
F1, F5
  • F1 Each share of Series B Convertible Preferred Stock automatically converted into Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date.
  • F5 The shares are held of record by Ascenta Capital Project Turing SPV, L.P., or Ascenta Capital Project Turing. As a Managing Member of Ascenta Capital Fund I, G.P., L.L.C., the General Partner of Ascenta Capital Project Turing, the reporting person shares voting and dispositive power with respect to the shares held of record by Ascenta Capital Project Turing. The reporting person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Exchange Act, except to the extent of his pecuniary interest therein, if any.
Open filing 0002151678-26-000007 Read from the filing’s XML Dispute this row
2026-10-16 Filed 2026-10-19Rachlin Evan Lockwood Director
C

Conversion of derivative security

Derivative security: Series B-3 Convertible Preferred Stock — underlying Common Stock (306,711)
Disposed (D)306,7110—0Indirect (I) See footnoteNo
F2, F3
  • F2 Each share of Series B-3 Convertible Preferred Stock automatically converted into Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date.
  • F3 The shares are held of record by Ascenta Capital Fund I, L.P., or Ascenta Capital Fund I. As a Managing Member of Ascenta Capital Fund I, G.P., L.L.C., the General Partner of Ascenta Capital Fund I, the reporting person shares voting and dispositive power with respect to the shares held of record by Ascenta Capital Fund I. The reporting person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Exchange Act, except to the extent of his pecuniary interest therein, if any.
Open filing 0002151678-26-000007 Read from the filing’s XML Dispute this row
2026-10-16 Filed 2026-10-19Rachlin Evan Lockwood Director
C

Conversion of derivative security

Derivative security: Convertible Promissory Notes — underlying Common Stock (410,762)
Disposed (D)410,7620—0Indirect (I) See footnoteNo
F4, F3
  • F4 The conversion price was equal to 85% of the Issuer's initial public offering price of $16.00 per share (reflecting a 15% discount).
  • F3 The shares are held of record by Ascenta Capital Fund I, L.P., or Ascenta Capital Fund I. As a Managing Member of Ascenta Capital Fund I, G.P., L.L.C., the General Partner of Ascenta Capital Fund I, the reporting person shares voting and dispositive power with respect to the shares held of record by Ascenta Capital Fund I. The reporting person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Exchange Act, except to the extent of his pecuniary interest therein, if any.
Open filing 0002151678-26-000007 Read from the filing’s XML Dispute this row
2026-10-14 Filed 2026-10-16Manby Frederick R Director · Officer: Chief Technology Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)132,2000—1,862,665Direct (D) No
F1
  • F1 The reported shares are represented by restricted stock units, or RSUs, which vest as follows: 25% of the RSUs vest on September 10, 2027 and the remaining RSUs vest in twelve equal quarterly installments beginning on December 10, 2027.
Open filing 0002156015-26-000005 Read from the filing’s XML Dispute this row
2026-10-14 Filed 2026-10-16Manby Frederick R Director · Officer: Chief Technology Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Employee Stock Option (right to buy) — underlying Common Stock (793,200) — exercise price 16
Acquired (A)793,2000—793,200Direct (D) No
F2
  • F2 Twenty-five percent of the shares subject to the option vest on October 14, 2027 and 1/48th of the shares vest monthly thereafter.
Open filing 0002156015-26-000005 Read from the filing’s XML Dispute this row
2026-10-14 Filed 2026-10-16Secora Michael Officer: CFO Chief Corp Dev Ofcr
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)28,4000—218,560Direct (D) No
F1
  • F1 The reported shares are represented by restricted stock units, or RSUs, which vest as follows: 25% of the RSUs vest on September 10, 2027 and the remaining RSUs vest in twelve equal quarterly installments beginning on December 10, 2027.
Open filing 0001855980-26-000007 Read from the filing’s XML Dispute this row
2026-10-14 Filed 2026-10-16Secora Michael Officer: CFO Chief Corp Dev Ofcr
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Employee Stock Option (right to buy) — underlying Common Stock (170,300) — exercise price 16
Acquired (A)170,3000—170,300Direct (D) No
F2
  • F2 Twenty-five percent of the shares subject to the option vest on October 14, 2027 and 1/48th of the shares vest monthly thereafter.
Open filing 0001855980-26-000007 Read from the filing’s XML Dispute this row
2026-10-14 Filed 2026-10-16EMSTER KURT VON Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (right to buy) — underlying Common Stock (20,300) — exercise price 16
Acquired (A)20,3000—20,300Direct (D) No
F1
  • F1 All of the shares subject to the option vest on October 14, 2027.
Open filing 0001252524-26-000005 Read from the filing’s XML Dispute this row
2026-10-14 Filed 2026-10-16Sharp Shalini Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (right to buy) — underlying Common Stock (20,300) — exercise price 16
Acquired (A)20,3000—20,300Direct (D) No
F1
  • F1 All of the shares subject to the option vest on October 14, 2027.
Open filing 0001377202-26-000012 Read from the filing’s XML Dispute this row
2026-10-14 Filed 2026-10-16Olson Peter A Officer: Chief Scientific Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)19,5000—30,909Direct (D) No
F1
  • F1 The reported shares are represented by restricted stock units, or RSUs, which vest as follows: 25% of the RSUs vest on September 10, 2027 and the remaining RSUs vest in twelve equal quarterly installments beginning on December 10, 2027.
Open filing 0002155824-26-000005 Read from the filing’s XML Dispute this row
2026-10-14 Filed 2026-10-16Olson Peter A Officer: Chief Scientific Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Employee Stock Option (right to buy) — underlying Common Stock (116,900) — exercise price 16
Acquired (A)116,9000—116,900Direct (D) No
F2
  • F2 Twenty-five percent of the shares subject to the option vest on October 14, 2027 and 1/48th of the shares vest monthly thereafter.
Open filing 0002155824-26-000005 Read from the filing’s XML Dispute this row
2026-10-14 Filed 2026-10-16Rachlin Evan Lockwood Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (right to buy) — underlying Common Stock (20,300) — exercise price 16
Acquired (A)20,3000—20,300Direct (D) No
F1
  • F1 All of the shares subject to the option vest on October 14, 2027.
Open filing 0002151678-26-000005 Read from the filing’s XML Dispute this row
2026-10-14 Filed 2026-10-16Vogelstein R Jacob Director · 10% owner
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (right to buy) — underlying Common Stock (20,300) — exercise price 16
Acquired (A)20,3000—20,300Direct (D) Yes
F1
  • F1 All of the shares subject to the option vest on October 14, 2027.
Open filing 0002154030-26-000005 Read from the filing’s XML Dispute this row
2026-10-14 Filed 2026-10-16TAGLIAFERRI MARY Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: 10/14/2026 — underlying Common Stock (20,300) — exercise price 16
Acquired (A)20,3000—20,300Direct (D) No
F1
  • F1 All of the shares subject to the option vest on October 14, 2027.
Open filing 0001323304-26-000010 Read from the filing’s XML Dispute this row
2026-10-14 Filed 2026-10-16Josephson Neil Officer: Chief Medical Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)31,0000—71,459Direct (D) No
F1
  • F1 The reported shares are represented by restricted stock units, or RSUs, which vest as follows: 25% of the RSUs vest on September 10, 2027 and the remaining RSUs vest in twelve equal quarterly installments beginning on December 10, 2027.
Open filing 0001864141-26-000007 Read from the filing’s XML Dispute this row
2026-10-14 Filed 2026-10-16Josephson Neil Officer: Chief Medical Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Employee Stock Option (right to buy) — underlying Common Stock (185,900) — exercise price 16
Acquired (A)185,9000—185,900Direct (D) No
F2
  • F2 Twenty-five percent of the shares subject to the option vest on October 14, 2027 and 1/48th of the shares vest monthly thereafter.
Open filing 0001864141-26-000007 Read from the filing’s XML Dispute this row
2026-10-14 Filed 2026-10-16RASTETTER WILLIAM H Director · Other: Chairperson of the Board
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (right to buy) — underlying Common Stock (40,600) — exercise price 16
Acquired (A)40,6000—40,600Direct (D) No
F1
  • F1 The shares subject to the option vest in 36 equal monthly installments beginning on November 14, 2026.
Open filing 0001205903-26-000011 Read from the filing’s XML Dispute this row
2026-10-14 Filed 2026-10-16Miller Thomas F. Director · Officer: Chief Executive Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)132,2000—1,410,756Direct (D) No
F1
  • F1 The reported shares are represented by restricted stock units, or RSUs, which vest as follows: 25% of the RSUs vest on September 10, 2027 and the remaining RSUs vest in twelve equal quarterly installments beginning on December 10, 2027.
Open filing 0002034921-26-000007 Read from the filing’s XML Dispute this row
2026-10-14 Filed 2026-10-16Miller Thomas F. Director · Officer: Chief Executive Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Employee Stock Option (right to buy) — underlying Common Stock (793,200) — exercise price 16
Acquired (A)793,2000—793,200Direct (D) No
F2
  • F2 Twenty-five percent of the shares subject to the option vest on October 14, 2027 and 1/48th of the shares vest monthly thereafter.
Open filing 0002034921-26-000007 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

No Form 13F position in this issuer is placed in the store. A holder not yet linked or not yet filed is absent, not zero.

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
Qatar Investment Authority Common Stock, par value $0.0015.82,804,360.0010/15/2026 Filed 2026-11-09SCHEDULE 13GOpen filing 0001441449-26-000012 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,694,798 filings read, dated 2004-06-14 to 2026-11-20: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
2015111,180
2016222,642
2017222,009
2018223,345
2019216,482
2020226,343
2021249,835
2022231,682
2023229,674
2024234,045
2025235,520
2026263,828

Filings made before the SEC required XML are listed, not extracted.

Back to Iambic Therapeutics, Inc.